| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.IJROBP.2011.07.020 |
| P698 | PubMed publication ID | 22284028 |
| P50 | author | Michael Lock | Q51061712 |
| Laura A. Dawson | Q56155563 | ||
| Morten Høyer | Q61142632 | ||
| P2093 | author name string | Karyn A Goodman | |
| Paul Okunieff | |||
| Sean Bydder | |||
| Alejandra Méndez Romero | |||
| Anand Swaminath | |||
| Brian Kavanagh | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | adaptive radiation therapy | Q180507 |
| P304 | page(s) | 1047-1057 | |
| P577 | publication date | 2012-03-01 | |
| P1433 | published in | International Journal of Radiation Oncology Biology Physics | Q2296252 |
| P1476 | title | Radiotherapy for liver metastases: a review of evidence | |
| P478 | volume | 82 |
| Q41322018 | 4DCT Simulation With Synchronized Contrast Injection in Liver SBRT Patients. |
| Q36798881 | A feasibility study evaluating the relationship between dose and focal liver reaction in stereotactic ablative radiotherapy for liver cancer based on intensity change of Gd-EOB-DTPA-enhanced magnetic resonance images |
| Q50010696 | A knowledge-based approach to automated planning for hepatocellular carcinoma |
| Q38825687 | A multivariable model to predict survival for patients with hepatic carcinoma or liver metastasis receiving radiotherapy |
| Q51799402 | A phase I study on stereotactic body radiotherapy of liver metastases based on functional treatment planning using positron emission tomography with 2-[18F]fluoro-2-deoxy-d-galactose. |
| Q51183954 | An international survey on liver metastases radiotherapy. |
| Q45828457 | Analysis of the factors affecting the safety of robotic stereotactic body radiation therapy for hepatocellular carcinoma patients |
| Q36944792 | Changing trends in radiation therapy technologies in the last year of life for patients diagnosed with metastatic cancer in the United States |
| Q50426141 | Combining deep learning with anatomical analysis for segmentation of the portal vein for liver SBRT planning |
| Q38826320 | Computed tomography imaging assessment of postexternal beam radiation changes of the liver. |
| Q39296799 | Dose to organ at risk and dose prescription in liver SBRT. |
| Q36512778 | Emerging approaches in the management of patients with neuroendocrine liver metastasis: role of liver-directed and systemic therapies |
| Q39097817 | Endoluminal and Interstitial Brachytherapy for the Treatment of Gastrointestinal Malignancies: a Systematic Review |
| Q52872889 | Evaluation of the blood supply and efficacy of transcatheter arterial chemoembolization for patients with liver metastasis using 18F-fluorodeoxyglucose positron emission tomography/computed tomography. |
| Q36151556 | Hepatic angiosarcoma may have fair survival nowadays. |
| Q37001905 | High-dose-rate interstitial brachytherapy for liver metastases: first study from India |
| Q34960297 | Highly conformal radiotherapy of primary and secondary lung malignancies |
| Q33890507 | Increasing use of advanced radiation therapy technologies in the last 30 days of life among patients dying as a result of cancer in the United States |
| Q33729963 | Integrating respiratory-gated PET-based target volume delineation in liver SBRT planning, a pilot study |
| Q38677025 | Liver metastases and SBRT: A new paradigm? |
| Q64114581 | NRG Oncology/RTOG 0438: A Phase 1 Trial of Highly Conformal Radiation Therapy for Liver Metastases |
| Q84705443 | New strategy in hepatic metastatic colorectal cancer: tomotherapy and capecitabine followed by hepatic surgical resection |
| Q38398883 | Non-operative therapies for colorectal liver metastases |
| Q50650651 | Optimization of stereotactic body radiotherapy treatment planning using a multicriteria optimization algorithm. |
| Q34801723 | Organized proteomic heterogeneity in colorectal cancer liver metastases and implications for therapies |
| Q36698026 | Patterns of prescribing radiotherapy and bevacizumab in nationwide practice - analysis of 101 designated cancer care hospitals in Japan |
| Q91781797 | Prognostic Significance of Tumor Location for Liver Cancer Radiotherapy |
| Q40182363 | Prospective phase II trial of regional hyperthermia and whole liver irradiation for numerous chemorefractory liver metastases from colorectal cancer |
| Q38685466 | Radiobiology of stereotactic body radiation therapy (SBRT). |
| Q49167503 | Radioembolization treatment for liver metastases |
| Q50624966 | Radiosensitivity Differences Between Liver Metastases Based on Primary Histology Suggest Implications for Clinical Outcomes After Stereotactic Body Radiation Therapy. |
| Q50357279 | Radiosurgery for liver metastases. A single institution experience |
| Q89706017 | Recursive partitioning model-based analysis for survival of colorectal cancer patients with lung and liver oligometastases treated with stereotactic body radiation therapy |
| Q51610928 | Respiratory gating based on internal electromagnetic motion monitoring during stereotactic liver radiation therapy: First results. |
| Q51768394 | Risk-adapted strategy partial liver irradiation for the treatment of large volume metastatic liver disease. |
| Q55220912 | SBRT planning for liver metastases: A focus on immobilization, motion management and planning imaging techniques. |
| Q36383996 | Scoring system predictive of survival for patients undergoing stereotactic body radiation therapy for liver tumors |
| Q37048588 | Single-dose radiosurgical treatment for hepatic metastases--therapeutic outcome of 138 treated lesions from a single institution |
| Q85411319 | Stereotactic ablative radiotherapy delivered by image-guided helical tomotherapy for extracranial oligometastases |
| Q39598540 | Stereotactic ablative radiotherapy for oligometastatic disease in liver |
| Q27008308 | Stereotactic body radiation therapy for liver metastases |
| Q50355067 | Stereotactic body radiation therapy for liver metastasis - The linac-based Greater Poland Cancer Centre practice |
| Q33769424 | Stereotactic body radiation therapy using the CyberKnife(®) system for patients with liver metastases |
| Q34320125 | Stereotactic body radiotherapy for oligometastases. |
| Q26796394 | Stereotactic body radiotherapy for the treatment of medically inoperable primary renal cell carcinoma: Current evidence and future directions |
| Q58790310 | Stereotactic body radiotherapy using the CyberKnife system in the treatment of patients with liver metastases: state of the art |
| Q38175120 | Stereotactic body radiotherapy: a critical review for nonradiation oncologists |
| Q33706721 | Strategies to tackle the challenges of external beam radiotherapy for liver tumors |
| Q37730019 | Surgical placement of biologic mesh spacers to displace bowel away from unresectable liver tumors followed by delivery of dose-intense radiation therapy |
| Q33823049 | Survey of stereotactic ablative body radiotherapy in the UK by the QA group on behalf of the UK SABR Consortium |
| Q57193222 | The Role of Liver-Directed Therapy in Metastatic Colorectal Cancer |
| Q55223014 | The SBRT database initiative of the German Society for Radiation Oncology (DEGRO): patterns of care and outcome analysis of stereotactic body radiotherapy (SBRT) for liver oligometastases in 474 patients with 623 metastases. |
| Q38967475 | The development of stereotactic body radiotherapy in the past decade: a global perspective |
| Q38625125 | The evolving role of radiotherapy in treatment of oligometastatic NSCLC. |
| Q61797349 | The impact of ionizing irradiation on liver detoxifying enzymes. A re-investigation |
| Q55084094 | The role of SBRT in oligometastatic patients with liver metastases from breast cancer. |
| Q39453628 | The utility of positron emission tomography/computed tomography in target delineation for stereotactic body radiotherapy for liver metastasis from primary gastric cancer: an illustrative case report and literature review |
| Q26998692 | Therapeutic procedures in liver metastases: Conventional and future measures |
| Q94336541 | Transarterial (chemo)embolisation versus chemotherapy for colorectal cancer liver metastases |
| Q38191920 | Treatment of metastatic liver tumors using stereotactic ablative radiotherapy |
| Q40774663 | Utilization of stereotactic ablative radiotherapy in the management of oligometastatic disease |
| Q90445705 | VEROnA Protocol: A Pilot, Open-Label, Single-Arm, Phase 0, Window-of-Opportunity Study of Vandetanib-Eluting Radiopaque Embolic Beads (BTG-002814) in Patients With Resectable Liver Malignancies |
Search more.